Triple helix-forming oligonucleotides conjugated to new inhibitors of topoisomerase II: synthesis and binding properties
M Duca, K Oussedik, A Ceccaldi, L Halby… - Bioconjugate …, 2005 - ACS Publications
Triplex-forming oligonucleotides (TFOs) are among the most specific DNA ligands and
represent an important tool for specific regulation of gene expression. TFOs have also been …
represent an important tool for specific regulation of gene expression. TFOs have also been …
Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides
M Duca, D Guianvarc'h, K Oussedik… - Nucleic acids …, 2006 - academic.oup.com
Human topoisomerase II (topo II) is the cellular target for a number of widely used antitumor
agents, such as etoposide (VP16). These agents 'poison'the enzyme and induce it to …
agents, such as etoposide (VP16). These agents 'poison'the enzyme and induce it to …
Exploring the cellular activity of camptothecin-triple-helix-forming oligonucleotide conjugates
PB Arimondo, CJ Thomas, K Oussedik… - … and cellular biology, 2006 - Taylor & Francis
Topoisomerase I is a ubiquitous DNA-cleaving enzyme and an important therapeutic target
in cancer chemotherapy for camptothecins (CPTs). These drugs stimulate DNA cleavage by …
in cancer chemotherapy for camptothecins (CPTs). These drugs stimulate DNA cleavage by …
[HTML][HTML] Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase I
PB Arimondo, A Boutorine, B Baldeyrou, C Bailly… - Journal of Biological …, 2002 - ASBMB
To achieve a sequence-specific DNA cleavage by topoisomerase I, derivatives of the
antitumor drug camptothecin have been covalently linked to triple helix-forming …
antitumor drug camptothecin have been covalently linked to triple helix-forming …
Linkage of a triple helix-forming oligonucleotide to amsacrine-4-carboxamide derivatives modulates the sequence-selectivity of topoisomerase II-mediated DNA …
P Arimondo, C Bailly, A Boutorine… - … Nucleotides & Nucleic …, 2000 - Taylor & Francis
Abstract Amsacrine-4-carboxamide-oligonucleotide conjugates were synthesized and
studied for their capacity to form DNA triple helices and to alter human topoisomerase II …
studied for their capacity to form DNA triple helices and to alter human topoisomerase II …
Quadruplex-duplex motifs as new topoisomerase I inhibitors
L Shuai, M Deng, D Zhang, Y Zhou… - … , Nucleotides and Nucleic …, 2010 - Taylor & Francis
In this article, 13 short chains that can form G-quadruplex and quadruplex-duplex motif have
been designed. Fourteen oligonucleotides, including 13 short chains as well as a reference …
been designed. Fourteen oligonucleotides, including 13 short chains as well as a reference …
Spatial organization of topoisomerase I‐mediated DNA cleavage induced by camptothecin–oligonucleotide conjugates
PB Arimondo, S Angenault, L Halby… - Nucleic acids …, 2003 - academic.oup.com
Triple helix‐forming oligonucleotides covalently linked to topoisomerase I inhibitors, in
particular the antitumor agent camptothecin, trigger topoisomerase I‐mediated DNA …
particular the antitumor agent camptothecin, trigger topoisomerase I‐mediated DNA …
Design of new anti-cancer agents based on topoisomerase poisons targeted to specific DNA sequences
PB Arimondo, C Helene - Current Medicinal Chemistry-Anti …, 2001 - ingentaconnect.com
There is considerable interest in the development of sequence-selective DNA drugs.
Chemical agents able to interfere with DNA topoisomerases-essential nuclear enzymes-are …
Chemical agents able to interfere with DNA topoisomerases-essential nuclear enzymes-are …
Sequence-specific targeting of duplex DNA using a camptothecin-triple helix forming oligonucleotide conjugate and topoisomerase I
M Matteucci, KY Lin, T Huang, R Wagner… - Journal of the …, 1997 - ACS Publications
The sequence-specific targeting of duplex DNA using triple helix-forming oligonucleotides
(TFOs) has attracted broad attention. 1 Currently, all such attempts to target DNA have used …
(TFOs) has attracted broad attention. 1 Currently, all such attempts to target DNA have used …
Activation of camptothecin derivatives by conjugation to triple helix-forming oligonucleotides
PB Arimondo, GS Laco, CJ Thomas, L Halby, D Pez… - Biochemistry, 2005 - ACS Publications
Topoisomerase I (topo I) is a ubiquitous DNA-cleaving enzyme and an important therapeutic
target in cancer chemotherapy. Camptothecins (CPTs) reversibly trap topo I in covalent …
target in cancer chemotherapy. Camptothecins (CPTs) reversibly trap topo I in covalent …